NSAIDs vs glucocorticoids
HRQOL ‐ not measured · acute gout
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Search
What do systematic reviews say?
40 questions · 40 findings · 16 reviews
No studies found 40 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Exercise therapy vs control
QoL · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Exercise therapy vs antidepressants
QoL · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Acupuncture vs no treatment
Potential harms ‐ quality of life (QoL) · patients with non‐specific chronic low back pain
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Exercise therapy vs adaptive pacing therapy
QoL · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Exercise therapy plus antidepressants vs antidepressants alone
QoL · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings table ‐ Metformin + megestrol vs megestrol
HRQOL ‐ not measured · endometrial hyerplasia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Metformin vs megestrol
HRQOL ‐ not measured · endometrial hyperplasia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Counselling vs usual care
HRQoL Kidney Disease Quality of Life (KDQOL‐36) (median · people with ESKD
The review found no eligible studies for this question.
1 finding from 1 review
- Psychosocial interventions for preventing and treating depression in dialysis patients 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Flutamide 250 mg once to b.i.d. vs spironolactone 100 mg
Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Ethinyl estradiol 35 μg + cyproterone acetate 2 mg vs ethinyl estradiol 30 μg + desogestrel 0.15 mg
Change in health‐related quality of life (HRQOL) ‐ not measured · patients with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Spironolactone 100 mg vs placebo
Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Finasteride 5 mg to 7.5 mg vs placebo
Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Metformin 500 mg to 2550 mg per day vs placebo
Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Finasteride 5 mg vs spironolactone 100 mg
Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Flutamide 250 mg once to b.i.d. vs metformin 1275 mg to 1700 mg per day
Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Finasteride 5 mg vs flutamide 250 mg once to b.i.d.
Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Flutamide 250 mg b.i.d. vs placebo
Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Relaxation vs usual care
Health‐related quality of life (HRQoL) · people with ESKD
The review found no eligible studies for this question.
1 finding from 1 review
- Psychosocial interventions for preventing and treating depression in dialysis patients 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Intervention not reported
Quality of life (QoL) We reported this outcome narratively in this review. Here, long‐term results (i.e., at the end of treatment) are presented. In the comparison PAZ versus SUN, QoL was measured using FACIT‐F (score range 0‐52; higher scores rep... · people with a confirmed diagnosis of advanced renal cell carcinoma (combined risk groups) without previous systemic anticancer therapy
The review found no eligible studies for this question.
1 finding from 1 review
- First‐line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta‐analysis 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found